Stock Symbol:

PLX

Company Name:

Protalix BioTherapeutics, Inc.

Company Description:

Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system primarily in the United States.

Investment Sector:

Biotechnology and Drugs

Predicted Split Months:

F-M-A-N

Stock Exchange:

AMEX

Predicted Split Price:

$19.00

Predicted Split Ratio:

5 for 4

5 Day Performance After Split:

3.1%

Prior Stock Splits:

0

Stock Split History:

None

Split Predictions Are Based Upon Historical Stock Market Data And Sector Trends. This Data Is For Educational Purposes Only.